Volume 3, 2012 - Online Edition | In This Issue
Looking at T Cell Function to Better Understand Lupus >
Back to Basics — T Cells... B Cells... And Lupus >
Researching B Cells Reveals Clues About Lupus >
Faces of Lupus: Sisterly Love in Michigan Benefits Everyone with Lupus >
Genetic Gateways to Understanding Lupus - New ALR Grant Awardees >
Lupus News Corner >
Lupus News Corner
Scientists Gather at European Convocation
Some of the world’s most brilliant scientists in the fields of rheumatology, lupus, and other autoimmune diseases gathered in Berlin, Germany in June of 2012 for the Annual Congress of European League Against Rheumatism (EULAR).
EULAR 2012 attracted more than 18,000 health care professionals in one of the most important forums of its kind. A wide range of topics on clinical innovations, translational science, and scientific research was covered.
Chair of the ALR Scientific Advisory Board, Dr. Peggy Crow attended the convention as a representative of the organization. “It was exciting to participate in such a large meeting and hear what our colleagues on the other side of the Atlantic are working on,” she said. “Like the ALR, EULAR fosters the sharing of ideas — and that’s essential to discovering treatments for rheumatology and lupus.”
EULAR endeavors to stimulate, promote, and support the research, prevention, treatment and rehabilitation of rheumatic diseases.
Congressional Lupus Caucus Formed
A bipartisan effort — spearheaded by Representatives Tom Rooney (R-FL), William Keating (D-MA), Ileana Ros-Lehtinen (R-FL), and Jim Moran (D-VA) — has resulted in the creation of a forum for Members of Congress to engage in dialogues about lupus. The aim is greater support for the advancement of lupus research as well as the promotion of awareness and understanding of the disease among the public and health professionals. The ALR applauds these representatives for championing efforts to bring lupus to the forefront of our nation’s consciousness — and for recognizing the needs of people who live with the disease.
New ALR Podcast: An Inside Look at the NIAMS
To grasp a better understanding of the role of the National Institutes of Health in helping to find new treatments for lupus, we spoke with Dr. Robert Carter, Deputy Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This conversation is the latest installment of the ALR’s Voices of Lupus podcast series. As former director of the Division of Clinical Immunology and Rheumatology at the University of Alabama, Dr. Carter offers an invaluable perspective on lupus research and the development of new treatments. And in speaking about the role of NIAMS, Dr. Carter put this simply: “to work to improve lives through discovery.”
To hear the conversation in its entirety, please click here.